Jeremy Murray

5.1k citations

36 papers · 1.8k indexed · h-index 22

Co-authors: Ingrid E. Wertz Dirksen E. Bussiere Wendy Sandoval Carrie M. Wilmot Simon E. V. Phillips Michael J. McPherson Peter F. Knowles Wayne J. Fairbrother
Topics: Ubiquitin and proteasome pathways (7 papers)Microbial metabolism and enzyme function (6 papers)Cancer-related Molecular Pathways (6 papers)
Cited by: Molecular Biology Biochemistry Cell Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Biochemistry
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Jeremy Murray

36 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jeremy Murray

Since Specialization

Citations

This map shows the geographic impact of Jeremy Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Murray more than expected).

Fields of papers citing papers by Jeremy Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Murray. The network helps show where Jeremy Murray may publish in the future.

Co-authorship network of co-authors of Jeremy Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Murray. A scholar is included among the top collaborators of Jeremy Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Murray. Jeremy Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms 2019 ·Drug Discovery Today Technologies ·Ingrid E. Wertz,Jeremy Murray	44
2	Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles 2017 ·ACS Medicinal Chemistry Letters ·Brian S. Safina,Richard L. Elliott,Andrew K. Forrest,Robert A. Heald,Jeremy Murray,Jim Nonomiya,Jodie Pang,Laurent Salphati,Eileen M. Seward,Steven T. Staben,Mark Ultsch,BinQing Wei,Wenqian Yang,Daniel P. Sutherlin	22
3	Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques 2017 ·Journal of Medicinal Chemistry ·Paola Di Lello,Richard Pastor,Jeremy Murray,Robert A. Blake,Frederick Cohen,Terry D. Crawford,Joy Drobnick,Jason Drummond,Lorna Kategaya,Tracy Kleinheinz,Till Maurer,Lionel Rougé,Xianrui Zhao,Ingrid E. Wertz,Chudi Ndubaku,Vickie Tsui	65
4	Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·Aaron Smith,Zhi‐Jie Ni,Daniel Poon,Zilin Huang,Zheng Chen,Qiong Zhang,Laura Tandeske,Hanne Merritt,Kevin Shoemaker,John S.D. Chan,Susan Kaufman,Kay Huh,Jeremy Murray,B.A. Appleton,Sandra W. Cowan‐Jacob,Clemens Scheufler,Takanori Kanazawa,Johanna M. Jansen,Darrin D. Stuart,Cynthia M. Shafer	8
5	Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death 2016 ·Cell Death and Differentiation ·M. Cristina de Almagro,Tatiana Goncharov,Anita Izrael-Tomasevic,(unknown),Matthias Kist,Eugene Varfolomeev,Xiumin Wu,Wyne P. Lee,Jeremy Murray,Joshua D. Webster,Kebing Yu,Donald S. Kirkpatrick,Kim Newton,Domagoj Vucic	95
6	Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation 2016 ·Structure ·Lionel Rougé,Travis W. Bainbridge,Michael C. M. Kwok,Raymond K. Tong,Paola Di Lello,Ingrid E. Wertz,Till Maurer,James A. Ernst,Jeremy Murray	80
7	Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Huiyong Hu,Xiaojing Wang,(unknown),Jae H. Chang,Steven Do,(unknown),Allen Ebens,Wendy Lee,Justin Q. Ly,Joseph P. Lyssikatos,Jeremy Murray,John G. Moffat,Qi Chao,Vickie Tsui,Heidi J.A. Wallweber,Aleksandr Kolesnikov	19
8	Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling 2015 ·Structure ·Cameron L. Noland,Sarah Gierke,Paul D. Schnier,Jeremy Murray,Wendy Sandoval,Meredith Sagolla,Anwesha Dey,Rami N. Hannoush,Wayne J. Fairbrother,Christian N. Cunningham	188
9	Tailoring Small Molecules for an Allosteric Site on Procaspase‐6 2013 ·ChemMedChem ·Jeremy Murray,Anthony M. Giannetti,Micah Steffek,Paul Gibbons,Brian R. Hearn,Frederick Cohen,Christine Tam,Christine D. Pozniak,Brandon Bravo,(unknown),Priyadarshini Jaishankar,Cuong Q. Ly,Xianrui Zhao,Yinyan Tang,Preeti Chugha,Michelle R. Arkin,John A. Flygare,Adam R. Renslo	24
10	Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaojing Wang,Steven Magnuson,(unknown),(unknown),Huiyong Hu,Vickie Tsui,Wei Deng,Jeremy Murray,Micah Steffek,Heidi J.A. Wallweber,John G. Moffat,Jason Drummond,Grace Chan,Eric B. Harstad,Allen Ebens	55
11	Modulating caspase activity: beyond the active site 2013 ·Current Opinion in Structural Biology ·Jeremy Murray,Adam R. Renslo	15
12	Identification of GNE-293, a potent and selective PI3Kδ inhibitor: Navigating in vitro genotoxicity while improving potency and selectivity 2013 ·Bioorganic & Medicinal Chemistry Letters ·Brian S. Safina,Zachary K. Sweeney,Jun Li,Bryan Chan,Angelina Bisconte,Diane E. Carrera,Georgette M. Castanedo,Michael Flagella,Robert A. Heald,Cristina Lewis,Jeremy Murray,Jim Nonomiya,Jodie Pang,Steve Price,Karin Reif,Laurent Salphati,Eileen M. Seward,BinQing Wei,Daniel P. Sutherlin	25
13	Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor 2013 ·Journal of Biological Chemistry ·Susmith Mukund,(unknown),Holly J. Clarke,Azadeh Madjidi,Jacob E. Corn,Lance Kates,Ganesh Kolumam,Vicky Chiang,Elizabeth Luis,Jeremy Murray,Yingnan Zhang,Isidro Hötzel,Christopher M. Koth,Bernard B. Allan	33
14	Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite 2012 ·Journal of Biological Chemistry ·Kenneth J. Katschke,Ping Wu,Rajkumar Ganesan,Robert F. Kelley,Mary Mathieu,Philip E. Hass,Jeremy Murray,Daniel Kirchhofer,Christian Wiesmann,Menno van Lookeren Campagne	66
15	The Development of Peptide-Based Tools for the Analysis of Angiogenesis 2011 ·Chemistry & Biology ·(unknown),Kerry Zobel,Herman Gill,Annie Ogasawara,Judith E. Flores,Jeff N. Tinianow,Alexander Vanderbilt,Ping Wu,Y. Gloria Meng,(unknown),Christian Wiesmann,Jeremy Murray,Jan Mařı́k,Kurt Deshayes	34
16	Targeting the Purinome 2009 ·Methods in molecular biology ·Jeremy Murray,Dirksen E. Bussiere	19
17	Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome 2006 ·Current Topics in Medicinal Chemistry ·Mark Knapp,Cornelia Bellamacina,Jeremy Murray,Dirksen E. Bussiere	13
18	Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies 2006 ·Bioorganic & Medicinal Chemistry Letters ·Xiaodong Lin,Jeremy Murray,(unknown),Michael Wang,Daniel T. W. Chu,Yasheen Zhou,(unknown),Susan Kaufman,Sylvia Ma,Eric Fang,Kenneth Crawford,Anne B. Jefferson	30
19	Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue 2002 ·Biochemical Journal ·(unknown),(unknown),Jeremy Murray,Carrie M. Wilmot,Simon E. V. Phillips,Michael J. McPherson,Peter F. Knowles	18
20	The Active Site Base Controls Cofactor Reactivity inEscherichia coliAmine Oxidase: X-ray Crystallographic Studies with Mutational Variants^, 1999 ·Biochemistry ·Jeremy Murray,(unknown),Carrie M. Wilmot,(unknown),Joachim Jaeger,Peter F. Knowles,Simon E. V. Phillips,Michael J. McPherson	69

About Jeremy Murray

Jeremy Murray is a scholar working on Molecular Biology, Biochemistry and Cell Biology, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Microbial metabolism and enzyme function (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Biochemistry (143 citations) and Cell Biology (270 citations). Jeremy Murray has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Ingrid E. Wertz, Dirksen E. Bussiere, Wendy Sandoval, Carrie M. Wilmot, Simon E. V. Phillips, Michael J. McPherson, Peter F. Knowles, Wayne J. Fairbrother, Markus Wartmann and Vito Guagnano. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact